Search results for "Prostate Cancer"

Results 91 - 100 of about 103 for "Prostate Cancer".

Warfarin recalled, type 2 diabetes drug approved

If the device is used during intraoperative radiation therapy for breast cancer, these particles can be mistaken for suspicious calcifications during follow-up X-rays or scans. ... Abiraterone acetate (Zytiga) to treat metastatic, castration-resistant
July 2011

Experts debate pros, cons of vitamin D

He offered a long list of medical problems that can be possibly prevented by vitamin D supplementation: schizophrenia; diabetes; multiple sclerosis; colorectal, breast and prostate cancer; heart attack; stroke; even respiratory ... Sun exposure causes
November 2009

More recalls, information on impurity found in ARBs

that uterine bleeding due to endometrial cancer is not dismissed as a diagnosis. ... Brand name: Aleve PM). Abiraterone acetate tablets (250 mg) to treat patients with metastatic castration-resistant prostate cancer.
January 2019

Are your patients health literate?

As the evidence on the utility of prostate-specific antigen screening for prostate cancer continues to be questioned, internists may wonder what to tell their patients about when, how and whether ... Screening can help detect prostate cancer early, but
July 2011

Safety nets catch at-risk patients

A second safety net aims to prevent lung cancer by focusing on incidental lung nodules. ... New safety nets that the team is working on include medication safety, prostate cancer, cervical cancer, breast cancer, and diagnostic errors, said Dr.
January 2020

Look for reasons if patients refuse advice

There's a whole list of options for low-grade prostate cancer, including prostatectomy, hormonal treatments, radiation and watchful waiting.
February 2014

CONFERENCE COVERAGE Information plus documentation a must for informed ...

In 1990, Dr. Gottesman was sued forlate diagnosis of a patient’s prostate cancer.He won the case, and one of the jurors toldhim that the deciding factor had beeninformed consent ... documentation showingthat the patient had been warned that abiopsy
December 2011

‘Smart’ drugs could be bad idea

Decisions about prostate cancer treatment can be notoriously complex, with patients and physicians choosing among such options as hormones, radiation, surgery, or watchful waiting. ... Our story in this issue looks at why some experts consider prostate
November 2017

Squeezing in the cancer screening talk

We have evidence, and practitioners should use that to improve cancer screening rates. ... When Dr. Mulhausen told an 86-year-old man he didn't need to screen for prostate cancer, for example, the patient responded, “So you're just going to give up
October 2019

Propoxyphene withdrawn, bevacizumab loses indication

In trials of patients with breast and prostate cancer, denosumab increased the length of time to SRE compared to zoledronic acid (Zometa). ... The breast cancer indication for bevacizumab was approved in February 2008 under the FDA's accelerated approval
February 2011

Prev   5   6   7   8   9   10   11   Next